U.S. Extracorporeal Membrane Oxygenation (ecmo) Cannula Market Size & Outlook
Related Markets
U.S. extracorporeal membrane oxygenation (ecmo) cannula market highlights
- The U.S. extracorporeal membrane oxygenation (ecmo) cannula market generated a revenue of USD 10.4 million in 2023 and is expected to reach USD 14.5 million by 2030.
- The U.S. market is expected to grow at a CAGR of 4.8% from 2024 to 2030.
- In terms of segment, veno-arterial was the largest revenue generating type in 2023.
- Veno-Arterial is the most lucrative type segment registering the fastest growth during the forecast period.
Extracorporeal membrane oxygenation (ecmo) cannula market data book summary
| Market revenue in 2023 | USD 10.4 million |
| Market revenue in 2030 | USD 14.5 million |
| Growth rate | 4.8% (CAGR from 2023 to 2030) |
| Largest segment | Veno-arterial |
| Fastest growing segment | Veno-Arterial |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Veno-Arterial, Veno-Venous, Arterio-Venous |
| Key market players worldwide | Medtronic PLC, LivaNova PLC, Edwards Lifesciences Corp, Getinge AB ADR, Fresenius Medical Care AG, Abbott Laboratories, Andocor |
Other key industry trends
- In terms of revenue, U.S. accounted for 32.4% of the global extracorporeal membrane oxygenation (ecmo) cannula market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. extracorporeal membrane oxygenation (ecmo) cannula market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 14.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Extracorporeal Membrane Oxygenation (ECMO) Cannula Market Scope
Extracorporeal Membrane Oxygenation (ECMO) Cannula Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Andocor | View profile | 11-50 | Hoogstraten, Antwerpen, Belgium, Europe | https://andocor.com |
| Fresenius Medical Care AG | View profile | 119845 | Else-Kroener-Strasse 1, Bad Homburg, HE, Germany, 61352 | https://www.freseniusmedicalcare.com |
| LivaNova PLC | View profile | 2900 | 20 Eastbourne Terrace, London, United Kingdom, W2 6LG | https://www.livanova.com |
| Edwards Lifesciences Corp | View profile | 19800 | One Edwards Way, Irvine, CA, United States, 92614 | https://www.edwards.com |
| Getinge AB ADR | View profile | 11862 | Lindholmspiren 7A, P.O. Box 8861, Gothenburg, Sweden, SE-417 56 | https://www.getinge.com |
| Medtronic PLC | View profile | 95000 | Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 | https://www.medtronic.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
U.S. extracorporeal membrane oxygenation (ecmo) cannula market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to extracorporeal membrane oxygenation (ecmo) cannula market will help companies and investors design strategic landscapes.
Veno-arterial was the largest segment with a revenue share of 44.23% in 2023. Horizon Databook has segmented the U.S. extracorporeal membrane oxygenation (ecmo) cannula market based on veno-arterial, veno-venous, arterio-venous covering the revenue growth of each sub-segment from 2018 to 2030.
- U.S. Extracorporeal Membrane Oxygenation (ECMO) Cannula Type Outlook (Revenue, USD Million, 2018-2030)
- Veno-Arterial
- Veno-Venous
- Arterio-Venous
- U.S. Extracorporeal Membrane Oxygenation (ECMO) Cannula Patient Type Outlook (Revenue, USD Million, 2018-2030)
- Neonates
- Pediatric
- Adult
- U.S. Extracorporeal Membrane Oxygenation (ECMO) Cannula Application Outlook (Revenue, USD Million, 2018-2030)
- Respiratory
- Cardiac
- ECPR
- U.S. Extracorporeal Membrane Oxygenation (ECMO) Cannula End Use Outlook (Revenue, USD Million, 2018-2030)
- Hospitals
- Ambulatory Surgical Centers
- Others
Reasons to subscribe to U.S. extracorporeal membrane oxygenation (ecmo) cannula market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. extracorporeal membrane oxygenation (ecmo) cannula market databook
-
Our clientele includes a mix of extracorporeal membrane oxygenation (ecmo) cannula market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. extracorporeal membrane oxygenation (ecmo) cannula market , including forecasts for subscribers. This country databook contains high-level insights into U.S. extracorporeal membrane oxygenation (ecmo) cannula market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. extracorporeal membrane oxygenation (ecmo) cannula market size, by type, 2018-2030 (US$M)
U.S. Extracorporeal Membrane Oxygenation (ECMO) Cannula Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
